Innovative Trials named a finalist at the Pharma Industry Award UK 2024

Innovative Trials, a global enterprise in clinical trial patient recruitment and retention, has been shortlisted in two categories of the 2024 Pharma Industry Awards UK, underscoring the company’s commitment to excellence and innovation within the pharmaceutical sector. The organization has been announced as a finalist for ‘Innovation of the Year’, for its groundbreaking patient support center for referral pre-screening & retention, Navigator, while company founder and CEO Kate Shaw is nominated for the ‘Woman in Pharma’ award.

 

 

 

Commenting on the news, Shaw said: “It is an honor and a privilege to be recognized for the work we are doing at Innovative Trials to advance excellence in the sector through creative thinking and new ideas. As a company, we are committed to accelerating the delivery of life-changing treatments to patients and this is what drives us to constantly develop new and better ways to support clinical trial participants, their families and caregivers, research sites and, of course, trial sponsors.  On being named a finalist for the Woman in Pharma award, Shaw said: “I am humbled by the nomination for Woman in Pharma, but any success that I have enjoyed is just as much due to the fantastic team around me. I look forward to celebrating the achievements of all those nominated at the awards night in September.”

 

 

Innovation of the Year award

Innovative Trials launched its Navigator service last year and it has already become widely known for revolutionizing patient and caregiver support during the entire clinical trial process and boosting recruitment and retention rates. In one study, Innovative Trials’ Navigator service expedited patient follow-up, ensuring potential participants did not lose interest in the study and saving study sites 5,850 hours in total. This allowed sites to concentrate on other aspects of the clinical trial and patient care instead.

 

Woman in Pharma

The Women in Pharma award recognizes the achievements of women who have made a significant contribution to the pharmaceutical sector in the UK. Kate Shaw has been nominated for her leadership, clinical research expertise and commitment to advancing global healthcare. During a career that has spanned more than three decades so far, she has led international healthcare initiatives and transformed patient recruitment approaches at one of the world’s leading pharmaceutical companies, which significantly improved trial efficiency and success rates in the process. At Innovative Trials, Shaw has grown the company into a global powerhouse for clinical trial patient recruitment and retention that is setting new industry benchmarks. Along the way, she has established herself as a key opinion leader in pharma and inspired countless professionals to consider a career in clinical research.

The Pharma Industry Awards UK celebrates the outstanding achievements and contributions of companies and individuals who are driving excellence in the UK’s pharmaceutical industry. The winners will be announced at a ceremony in Birmingham on Wednesday 18 September.

 

For more information about Innovative Trials and its patient recruitment and retention services, please visit www.innovativetrials.com

-Ends-

For more information, or to request an interview with Kate Shaw, please contact Laura Gibson at Presence Media via +44 7771 933609 or [email protected]

Notes to editors

About Innovative Trials

Innovative Trials is a prominent international company specializing in patient recruitment and retention for clinical trials. Boasting 14 years of experience, Innovative Trials provides three fundamental services in this domain:

  • 1:1 In-country Recruitment Coaching & Site Support, facilitated by ‘boots-on-the-ground’ local patient recruitment experts operating in more than 70 countries,
  • Site & Patients Educational Materials,
  • Navigator, a patient support center for referral pre-screening & retention and 1:1 support service for patients, caregivers and sites. 

With expertise in over 400 trials, 25 therapeutic areas, and over 90 conditions, Innovative Trials has established itself as a trusted and seasoned partner for pharmaceutical companies, contract research organizations (CROs) and biotechnology companies. For more information, visit www.innovativetrials.com